656 related articles for article (PubMed ID: 25700037)
1. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.
Gyöngyösi M; Wojakowski W; Lemarchand P; Lunde K; Tendera M; Bartunek J; Marban E; Assmus B; Henry TD; Traverse JH; Moyé LA; Sürder D; Corti R; Huikuri H; Miettinen J; Wöhrle J; Obradovic S; Roncalli J; Malliaras K; Pokushalov E; Romanov A; Kastrup J; Bergmann MW; Atsma DE; Diederichsen A; Edes I; Benedek I; Benedek T; Pejkov H; Nyolczas N; Pavo N; Bergler-Klein J; Pavo IJ; Sylven C; Berti S; Navarese EP; Maurer G;
Circ Res; 2015 Apr; 116(8):1346-60. PubMed ID: 25700037
[TBL] [Abstract][Full Text] [Related]
2. Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty.
Miszalski-Jamka T; Klimeczek P; Tomala M; Krupiński M; Zawadowski G; Noelting J; Lada M; Sip K; Banyś R; Mazur W; Kereiakes DJ; Zmudka K; Pasowicz M
JACC Cardiovasc Imaging; 2010 Dec; 3(12):1237-46. PubMed ID: 21163452
[TBL] [Abstract][Full Text] [Related]
3. Short-Term Effect of Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Clinical Trials.
Cong XQ; Li Y; Zhao X; Dai YJ; Liu Y
J Cardiovasc Transl Res; 2015 Jun; 8(4):221-31. PubMed ID: 25953677
[TBL] [Abstract][Full Text] [Related]
4. Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials.
Zhang S; Sun A; Xu D; Yao K; Huang Z; Jin H; Wang K; Zou Y; Ge J
Clin Cardiol; 2009 Aug; 32(8):458-66. PubMed ID: 19685520
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
[TBL] [Abstract][Full Text] [Related]
6. Effect of direct intramyocardial autologous stem cell grafting in the sub-acute phase after myocardial infarction.
Laguna G; DI Stefano S; Maroto L; Fulquet E; Echevarría JR; Revilla A; Urueña N; Sevilla T; Arnold R; Ramos B; Gutiérrez H; Serrador A; San Román JA
J Cardiovasc Surg (Torino); 2018 Apr; 59(2):259-267. PubMed ID: 29582623
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy.
Leistner DM; Fischer-Rasokat U; Honold J; Seeger FH; Schächinger V; Lehmann R; Martin H; Burck I; Urbich C; Dimmeler S; Zeiher AM; Assmus B
Clin Res Cardiol; 2011 Oct; 100(10):925-34. PubMed ID: 21633921
[TBL] [Abstract][Full Text] [Related]
8. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
10. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis.
Jiang M; He B; Zhang Q; Ge H; Zang MH; Han ZH; Liu JP; Li JH; Zhang Q; Li HB; Jin Y; He Q; Gong XR; Yin XY
Expert Opin Biol Ther; 2010 May; 10(5):667-80. PubMed ID: 20384520
[TBL] [Abstract][Full Text] [Related]
12. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design.
Mansour S; Roy DC; Bouchard V; Nguyen BK; Stevens LM; Gobeil F; Rivard A; Leclerc G; Reeves F; Noiseux N
J Cardiovasc Transl Res; 2010 Apr; 3(2):153-9. PubMed ID: 20560029
[TBL] [Abstract][Full Text] [Related]
13. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.
Schächinger V; Assmus B; Britten MB; Honold J; Lehmann R; Teupe C; Abolmaali ND; Vogl TJ; Hofmann WK; Martin H; Dimmeler S; Zeiher AM
J Am Coll Cardiol; 2004 Oct; 44(8):1690-9. PubMed ID: 15489105
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
Liu B; Duan CY; Luo CF; Ou CW; Sun K; Wu ZY; Huang H; Cheng CF; Li YP; Chen MS
Int J Cardiol; 2014 Dec; 177(3):764-70. PubMed ID: 25465825
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
18. Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials.
de Jong R; Houtgraaf JH; Samiei S; Boersma E; Duckers HJ
Circ Cardiovasc Interv; 2014 Apr; 7(2):156-67. PubMed ID: 24668227
[TBL] [Abstract][Full Text] [Related]
19. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.
Lipinski MJ; Biondi-Zoccai GG; Abbate A; Khianey R; Sheiban I; Bartunek J; Vanderheyden M; Kim HS; Kang HJ; Strauer BE; Vetrovec GW
J Am Coll Cardiol; 2007 Oct; 50(18):1761-7. PubMed ID: 17964040
[TBL] [Abstract][Full Text] [Related]
20. The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial.
Leone AM; D'Amario D; Teofili L; Basile E; Cannata F; Graziani F; Marzilli M; Russo AM; Tarantini G; Ceconi C; Leone G; Trani C; Rebuzzi AG; Crea F
Trials; 2016 Feb; 17():97. PubMed ID: 26891753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
